What is Standard Carrier Screening?

Standard screens one person, usually the female partner, for the three conditions Medicare funds: cystic fibrosis, spinal muscular atrophy and fragile X syndrome. Here’s what that means and how your partner fits in.

Elucia Standard carrier screening kit box with one sample tube

What it looks at

Genes are pieces of DNA that help tell our bodies how to grow and work. We all have small differences in our genes. Most do not cause any problems.

Sometimes, a difference in a gene can cause an inherited condition if it is passed on in a particular way. Carrier screening looks for these specific differences.

For example, screening commonly includes:

Cystic fibrosis, which mainly affects the lungs and digestive system.
Spinal muscular atrophy, which affects the nerves that control muscles and can cause serious muscle weakness.
Fragile X syndrome, which can affect learning, development and behaviour.

Different carrier screens look at different numbers of conditions. Expanded screening looks across many more genes than the standard three-condition screen.

How your result works

Standard tests one of you first, usually the female partner.

Cystic fibrosis and SMA only affect a pregnancy when both partners carry a change in the same gene, so if you carry one, your partner can be tested next, and Medicare covers that too.

Fragile X is passed on through the mother, so her result tells you what you need to know on its own.

If you and your partner show an increased chance, a genetic counsellor talks you through what it means for your plans, at no extra cost.

What a result tells you

A carrier result does not mean your child will have a condition.

For many conditions, your partner’s result helps show whether there is an increased chance for a future child.

A clear result also does not rule out every genetic condition.

A clearer place to start.

Carrier screening helps you know where you stand and plan for your family with peace of mind.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.

1. Total Medicare-funded standard carrier screening tests in Australia (items 73451 and 73452), Nov 2023 to Aug 2026. Excludes privately paid screening. Sources: Services Australia MBS item data (data.gov.au); Research Square preprint, 2025.

2. Centre for Genetics Education, NSW Health. Reproductive carrier screening. 2024.

3. Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Genetic Carrier Screening (C-Obs 63). Interim update July 2024.

* May be $0, bulk billed for eligible patients under Medicare item 73451. Medicare covers Standard carrier screening once per lifetime, and eligibility is confirmed before testing proceeds. Without Medicare, a fee applies to the screening and the consultation. Medicare doesn’t cover Expanded screening.


† Our Standard carrier screening results usually take about 3 weeks from when the lab receives your swab. Industry-leading based on our laboratory partner’s turnaround data, October 2026.


‡ Every test includes a telehealth GP consult. A genetic counsellor consult is also included if your results show an increased chance (a higher-risk result).

Elucia screening identifies carrier status. Talk to your healthcare provider about clinical decisions.